S&P 500
(0.12%) 5 303.27 points
Dow Jones
(0.34%) 40 004 points
Nasdaq
(-0.07%) 16 686 points
Oil
(-0.10%) $79.98
Gas
(1.37%) $2.66
Gold
(0.86%) $2 438.20
Silver
(4.07%) $32.53
Platinum
(0.95%) $1 100.40
USD/EUR
(-0.03%) $0.920
USD/NOK
(-0.05%) $10.67
USD/GBP
(0.04%) $0.787
USD/RUB
(0.09%) $91.05

Realtime updates for Crossject SA [ALCJ.PA]

Exchange: EURONEXT Industry: Medical Instruments & Supplies
Last Updated17 May 2024 @ 11:35

-1.02% 1.950

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector...

Stats
Today's Volume 48 627.00
Average Volume 82 614.00
Market Cap 79.85M
EPS €0 ( 2024-04-24 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -5.42
ATR14 €0.00600 (0.30%)

Volume Correlation

Long: 0.16 (neutral)
Short: 0.26 (neutral)
Signal:(55.577) Neutral

Crossject SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Crossject SA Correlation - Currency/Commodity

The country flag -0.57
( weak negative )
The country flag -0.22
( neutral )
The country flag 0.00
( neutral )
The country flag -0.46
( neutral )
The country flag 0.00
( neutral )
The country flag 0.26
( neutral )

Crossject SA Financials

Annual 2023
Revenue: €145 000
Gross Profit: €-18.35M (-12 657.24 %)
EPS: €-0.230
FY 2023
Revenue: €145 000
Gross Profit: €-18.35M (-12 657.24 %)
EPS: €-0.230
FY 2022
Revenue: €954 000
Gross Profit: €-13.89M (-1 456.39 %)
EPS: €-0.310
FY 2021
Revenue: €912 000
Gross Profit: €-390 000 (-42.76 %)
EPS: €-0.408

Financial Reports:

No articles found.

Crossject SA Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Crossject SA

Crossject Société Anonyme develops needle-free injection systems. The company develops ZENEO, a needle-free, prefilled, and single-use auto-injector. Its clinical stage drugs comprise Sumatriptan, which is used for of treatment migraines and cluster headaches; Adrenaline for treating anaphylactic shock; Hydrocortisone that is used for treatment of acute adrenal crisis; Midazolam for treating epileptic seizure; Naloxone used for treatment of overdose; Apomorphine, for treating temporary paralysis in parkinson's disease; Methotrexate used for treatment of rheumatoid arthritis; and Terbutaline, for treating severe asthma crisis. The company was founded in 1997 and is based in Dijon, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators